Literature DB >> 6723549

Management of mucocutaneous herpes simplex virus infections.

S E Straus, M Seidlin, H Takiff.   

Abstract

Herpes simplex virus type 1 and 2 are causes of common inflammatory conditions of the mucous membranes and skin. The proper management of these infections begins with an accurate diagnosis. Viral cultures should be performed whenever possible. Patients should be counselled regarding the proper care of lesions, the risk of complications, the likelihood of experiencing recurrent infection, and should be urged to avoid intimate contact while lesions are active. Antiviral therapy is now available to ameliorate the symptoms and shorten the duration of infection in selected patients, but does not prevent recurrences. Topical, oral and intravenous preparations of acyclovir are effective in treatment of primary herpes simplex infections. Immunosuppressed patients with herpes simplex infections also benefit from acyclovir therapy. Oral activity has some activity in ameliorating recurrent genital herpes and should be considered for patients who are particularly troubled by their infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723549     DOI: 10.2165/00003495-198427040-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  7 in total

1.  The course of untreated recurrent genital herpes simplex infection in 27 women.

Authors:  M E Guinan; J MacCalman; E R Kern; J C Overall; S L Spruance
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

2.  Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes.

Authors:  A E Nilsen; T Aasen; A M Halsos; B R Kinge; E A Tjøtta; K Wikström; A P Fiddian
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

3.  The natural history of herpes simplex virus infection of mother and newborn.

Authors:  R J Whitley; A J Nahmias; A M Visintine; C L Fleming; C A Alford
Journal:  Pediatrics       Date:  1980-10       Impact factor: 7.124

4.  The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.

Authors:  S L Spruance; J C Overall; E R Kern; G G Krueger; V Pliam; W Miller
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

Review 5.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

6.  Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial.

Authors:  J C Wade; B Newton; C McLaren; N Flournoy; R E Keeney; J D Meyers
Journal:  Ann Intern Med       Date:  1982-03       Impact factor: 25.391

7.  Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response.

Authors:  W C Reeves; L Corey; H G Adams; L A Vontver; K K Holmes
Journal:  N Engl J Med       Date:  1981-08-06       Impact factor: 91.245

  7 in total
  1 in total

1.  Topical Acyclovir for Recurrent Herpes Labialis in Primary Care: Critical appraisal.

Authors:  G Worrall
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.